Proton pump inhibitors may lead to cognitive decline among breast cancer survivors

Breast cancer survivors often take proton pump inhibitors to manage gastrointestinal symptoms related to their treatment.Physicians also may recommend longer-term use of proton pump inhibitors (PPIs) to protect the gastric mucosal layer, which can deteriorate as a result of chemotherapy.These off-label uses of PPIs may lead to cognitive problems for breast cancer survivors, according to results of a study by Annelise A. Madison, MA, a graduate student in clinical psychology at The Ohio State University, and colleagues.Breast cancer survivors are more susceptible to cognitive decline than theRead More

Share on facebook
Share on twitter
Share on linkedin